Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.
Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while ...
Chennai-based Kauvery Hospital launched advanced electro-anatomical mapping technology on Thursday for the treatment of ...
Kauvery Hospital, Vadapalani, has launched an advanced electroanatomical mapping technology to accurately diagnose and treat complex heart rhythm disorders.
Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while exercising, new ...
Kauvery Hospital in Chennai launches advanced 3D technology for precise diagnosis and treatment of complex heart arrhythmias.
Cardiac Electrophysiology Institute Expands Catheter Ablation Access For Los Angeles Heart Rhythm Patients. <a href = target= ...
North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator (WCD) saved 143 patients between ...
Trinity Health Ann Arbor has completed Michigan’s first implant of the world’s smallest device designed to help treat ...
The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.
Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results